[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prep-uptake\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prep-uptake":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,43,72,104,132,153,181,204,238],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100513690","leveraging-chatbot-to-improve-prep-in-the-southern-united-states-100513690",false,"NCT05968755","Leveraging Chatbot to Improve PrEP in the Southern United States","Leveraging Chatbot Technology to Improve PrEP Awareness and Uptake Among Black MSM in the Southern United States","Inclusion Criteria:\n\n* Being cisgender Black male\n* Being aged ≥ 18 years\n* Having Internet access\n* Speaking English\n* Self-reporting condomless sex with another man in the past 6 months\n* HIV negative or untested.\n\nExclusion Criteria:\n\n* Having lived in the US South less than 3 months\n* Having received antiretroviral therapy (ART) treatment.",true,"MALE","18 Years",{"count":20,"type":21},145,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study is to develop a chatbot intervention to promote PrEP awareness and uptake among Black men who have sex with men (MSM) in the Southern United States.",[27,28,29],"HIV Prevention","PrEP Awareness","PrEP Uptake","NOT_YET_RECRUITING","2026-07-01",{"date":33,"type":34},"2026-07-02","ACTUAL",{"date":36,"type":21},"2026-07-20",{"date":38,"type":21},"2027-07-01",{"name":40,"class":41},"Yale University","OTHER",4,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":22,"phases":51,"briefSummary":52,"conditions":53,"keywords":57,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":68,"leadSponsor":70,"locationsCount":4},"100614575","reducing-co-occurring-substance-use-and-hiv-risk-among-stimulant-using-men-at-high-risk-for-hiv-in-the-united-states-of-america-100614575","NCT07281378","Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.","Inclusion Criteria:\n\n1. be 18 years of age or older;\n2. be sexually active cisgender men at high risk for HIV (foreign and US-born, residing in the US)-reporting any condomless anal sex (CAS) in the past three months with a man;\n3. report use of stimulant (i.e., methamphetamine, powder cocaine, or crack-cocaine) at least one day in the past three or six month;\n4. have HIV-negative serostatus;\n5. be bilingual (Spanish and English), or Spanish or English monolingual;\n6. meet CDC criteria for PrEP eligibility.\n\nExclusion Criteria:\n\n1. display diminished capacity to consent (e.g., cognitive impairment); or\n2. severe psychiatric symptoms (e.g., psychosis) that require more intensive treatment;\n3. if they are HIV positive or living with HIV;\n4. if they are already taking PrEP; and\n5. if the participant can't consent to participate in English or Spanish.",{"count":50,"type":21},84,[24],"This intervention will focus on stimulant-using men at high risk for HIV who are in need of tailored behavioral interventions to mitigate co-occurring stimulant use and HIV risk in the era of pre-exposure prophylaxis (PrEP). The study is a pilot randomized controlled trial to evaluate the adaptation, feasibility, acceptability, and preliminary efficacy of a behavioral intervention.",[54,29,55,56],"Drug Use Disorders","PrEP Adherence","HIV Risk Behavior",[58,59,60,61,62,63],"PrEP","PrEP uptake","HIV","substance use","stimulant use","men at high risk for HIV","2026-06-29",{"date":66,"type":34},"2026-06-30",{"date":36,"type":21},{"date":69,"type":21},"2027-12-31",{"name":71,"class":41},"University of Florida",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":79,"minAge":18,"maxAge":4,"enrollmentInfo":80,"targetDuration":4,"studyType":82,"phases":4,"briefSummary":83,"conditions":84,"keywords":89,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":4},"100638250","prep-lana-pre-exposure-prophylaxis--long-acting-novel-antiviral-agent-100638250","NCT07620730","PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)","PrEP-LANA","Inclusion Criteria:\n\nParticipants of any gender, ethnicity or socio-economic group who meet all the following criteria are eligible for inclusion in this study:\n\n* Adults who are aged \\> 18 years at time of consent (including people of child-bearing capacity and age, non-pregnant or pregnant adults)\n* Attending a participating NHS sexual healthcare service\n* Prescribed LA CAB for PrEP according to NICE and NHS eligibility criteria (including those newly prescribed and those already using LA CAB)\n* Non-reactive \u002F negative HIV Antigen\u002FAntibody test and HIV RNA test at time of LA CAB for PrEP initiation (performed under routine care)\n* Able and willing and able to give informed consent to all study procedures prior to inclusion\n\nExclusion Criteria:\n\nPrEP user participants who meet any of the following criteria are ineligible for inclusion in this study:\n\n* One or more reactive or positive HIV test results at enrolment visit, even if HIV infection is not confirmed.\n* Currently enrolled in interventional trial of PrEP agents, HIV vaccine trial or experimental medication.\n* Plan to relocate out of the area during the study period. Note: \"Plan to relocate out of the area\" is defined as a stated intention at enrolment to move residence outside the catchment area of a participating study site during the study period, such that ongoing clinical management would likely transfer to a non-participating team.","ALL",{"count":81,"type":21},220,"OBSERVATIONAL","The goal of this 12-month implementation science study is to generate the evidence required to ensure long-acting cabotegravir (LA CAB) as pre-exposure prophylaxis (PrEP) can be delivered in an equitable manner within the NHS. This study will recruit both PrEP users and healthcare professionals (HCPs).\n\nThe main questions it aims to answer are:\n\n* What do healthcare providers think about the feasibility of delivering LA CAB PrEP within sexual health services in the NHS?\n* How many participants stay on\u002Fremain consistent with LA CAB PrEP injections at Month 12 (PrEP persistence)?\n\nParticipants (200 PrEP users) will be followed for 12-months and asked to complete surveys at 3 study visits. A subset of 20 participants will also be asked to complete interviews about their experiences. We will also ask 20 HCPs at participating locations to complete surveys and interviews at both baseline and month 12.\n\nA core principle of equity (understanding any difference in impact on underserved populations) will be applied throughout the study. To ensure representation of a diverse group of participants that reflects the demographic groups most affected by incident HIV and most underserved by PrEP in the UK, enrolment targets will be applied and meticulously managed by the central study team, as follows:\n\n* A cap of 30% (n=60) will be applied to recruitment of White cisgender men who have sex with men who are not otherwise part of other under-represented groups (as defined below),\n* At least 70%% (n=140) of participants will represent groups currently underserved by PrEP and fall into one (or more) of the following socio-demographic categories: women (defined cisgender or transgender) OR as transgender men OR non-binary individuals OR age\\\u003C25 yrs, OR sex workers OR people who inject drugs OR racially minoritised heterosexual men.",[58,85,86,29,87,88],"PrEP Adherence Experiences","PrEP Adherence Perspectives","Equity","Community Setting",[58,90,77,91,92,93,87,94],"Patient and public involvement and engagement","LA CAB","Cabotegravir","Long-acting PrEP","community setting","2026-05-28",{"date":97,"type":34},"2026-06-02",{"date":99,"type":21},"2026-10",{"date":101,"type":21},"2028-06",{"name":103,"class":41},"Queen Mary University of London",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":16,"sex":79,"minAge":18,"maxAge":4,"enrollmentInfo":111,"targetDuration":4,"studyType":22,"phases":113,"briefSummary":114,"conditions":115,"keywords":120,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":127,"leadSponsor":129,"locationsCount":131},"100607926","hiv-self-testing-for-partners-of-hiv-uninfected-postpartum-women-100607926","NCT07194902","HIV Self-testing for Partners of HIV-uninfected Postpartum Women","HIV Self-testing for Partners of HIV-uninfected Postpartum Women to Facilitate PrEP and Antiretroviral Therapy Uptake to Promote HIV Treatment and Prevention","Female Inclusion Criteria:\n\n* woman\n* Age ≥18\n* ≥30 weeks pregnant per medical record due date\n* non-reactive third trimester HIV test (verified from their antenatal care chart)\n* reporting at least one unknown-serostatus partner\n* fluent in English or isiZulu\n* willing to give researchers permission to contact them for repeated assessments\n* able to provide informed consent\n\nMale Inclusion Criteria: partners meeting the inclusion criteria as described above, and who complete verification questions to confirm their identity and status as the partners of the enrolled female participants. Additional inclusion criteria for men include:\n\n* man\n* Age ≥18\n* partner of enrolled women, confirmed via couples verification tool\n* fluent in English or isiZulu\n* willing to give researchers permission to contact them\n* able to provide informed consent.\n\nExclusion Criteria: Individuals with significant psychiatric illness that could interfere with participation or the ability to provide informed consent will be excluded at the discretion of the study team.",{"count":112,"type":21},120,[24],"The purpose of this study is to test the feasibility and acceptability of a combination intervention to promote HIV self-testing (HIVST) for Partners and PrEP uptake for HIV-uninfected Postpartum Women (\"H4P\"). H4P includes evidence-based cognitive behavioral therapy (CBT) strategies, such as communication skills training, motivational interviewing, and problem-solving. The investigators will conduct a randomized pilot trial of the H4P intervention to evaluate the feasibility, acceptability, and preliminary effectiveness of a multi-step PrEP uptake and HIV self-test kit intervention for postpartum HIV-uninfected women (N = 60 and their male partners) who report a partner of unknown serostatus, and their partners, in the province of KwaZulu-Natal, South Africa.",[116,117,29,118,119,27],"HIV Self-testing","Male Partners of HIV-negative Postpartum Women","Feasibility","Acceptability",[27,58,121],"HIV Self-Testing","RECRUITING","2026-03-19",{"date":125,"type":34},"2026-03-23",{"date":123,"type":34},{"date":128,"type":21},"2026-08-28",{"name":130,"class":41},"Massachusetts General Hospital",1,{"id":133,"slug":134,"hasResults":11,"nctId":135,"briefTitle":136,"officialTitle":136,"acronym":137,"eligibilityCriteria":138,"healthyVolunteers":11,"sex":79,"minAge":18,"maxAge":4,"enrollmentInfo":139,"targetDuration":4,"studyType":22,"phases":141,"briefSummary":142,"conditions":143,"keywords":4,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":147,"completionDateStruct":149,"leadSponsor":151,"locationsCount":131},"100610750","protect-al-prep-optimization-through-enhanced-continuum-tracking-100610750","NCT07231640","PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking","PrOTECT AL","Inclusion Criteria:\n\n* currently practicing providers (either a clinician, nurse or medical assistant), OR 2) clinical administrator (e.g., someone in a leadership role within the PrEP clinic), OR 3) a data manager (i.e., someone who collects, enters and or manages data within the clinic) AND\n* English speaking\n* Age ≥ 18.\n\nExclusion Criteria:\n\n* Not one of the seven participating sites",{"count":140,"type":21},56,[24],"The purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care disparities, allocate resources strategically, identify and address care gaps in the delivery of PrEP services, and gauge its impact on HIV prevention efforts.",[60,58,29,27],"2026-02-19",{"date":146,"type":34},"2026-02-20",{"date":148,"type":34},"2026-02-09",{"date":150,"type":21},"2030-04",{"name":152,"class":41},"University of Alabama at Birmingham",{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":79,"minAge":18,"maxAge":4,"enrollmentInfo":161,"targetDuration":4,"studyType":22,"phases":163,"briefSummary":164,"conditions":165,"keywords":169,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":131},"100567451","enhancing-hiv-prevention-and-reducing-alcohol-use-among-people-receiving-sti-care-in-lilongwe-malawi-100567451","NCT06668363","Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi","Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi: A Pilot Implementation Study","Treat4All","Inclusion Criteria:\n\n* Men and women age 18 years or older.\n* Receiving care at Bwaila STI clinic.\n* Report recent heavy drinking (greater than or equal to 4 drinks a day in the past 30 days for men and greater than or equal to 3 drinks a day in the past 30 days for women\n* Willing to receive an HIV test at study enrollment, if not previously diagnosed Report not taking ART, recent suboptimal adherence to ART, or recent history of unsuppressed HIV viral load \\[for PWH\\] or no recent oral PrEP use (self-reported taking no PrEP pills in past 7 days) \\[for those at risk of HIV\\]\n* Plan to reside in the Lilongwe area for at least 6 months.\n* Not participating in other HIV or alcohol programs\n* Ability and willingness of participant to provide informed consent.\n* Willingness to provide contact\u002Flocator information to be contacted for follow up study activities.\n\nExclusion Criteria:\n\n* Unable to participate in study activities due to psychological disturbance, cognitive impairment, or threatening behavior\n* Pregnant or breastfeeding\n* At risk of experiencing alcohol-related withdrawal symptoms\n* Acute physical or mental illness, including suicidal thoughts or behaviors\n* Participating in in other HIV or alcohol programs\n* Active drug dependence that would interfere with adherence to study requirements.\n* History of using injectible PrEP\n* Any other condition that in the opinion of the study investigator would compromise the safety of the study participant or study staff or would prevent proper conduct of the study.",{"count":162,"type":21},160,[24],"Purpose: To evaluate short-term efficacy and implementation of Treat4All, an alcohol reduction evidence-based intervention, for decreasing heavy drinking and optimizing HIV outcomes (viral suppression among People with HIV (PWH); Pre-exposure prophylaxis (PrEP) use among those at high risk of HIV)\n\nParticipants: Approximately 160 participants aged 18 years or older will be enrolled into this study.\n\nEligible participants will be recruited from two groups of individuals:\n\nPersons at risk of HIV: Individuals receiving (STI) care who report recent heavy drinking (n=80) and no recent use of PrEP. Persons with HIV: Individuals with HIV who report recent heavy drinking and either a history of unsuppressed viral load or recent suboptimal adherence to ART (n=80).\n\nProcedures (methods): Pilot two-arm randomized controlled trial (1:1; Treat4All Intervention vs Usual Care)",[166,29,167,27,168],"Alcohol Consumption","Recent Heavy Drinking","HIV Treatment",[58,60,27,170,171],"Alcohol reduction","Alcohol","2026-01-28",{"date":174,"type":34},"2026-01-30",{"date":176,"type":34},"2024-12-12",{"date":178,"type":21},"2026-06",{"name":180,"class":41},"University of North Carolina, Chapel Hill",{"id":182,"slug":183,"hasResults":11,"nctId":184,"briefTitle":185,"officialTitle":185,"acronym":4,"eligibilityCriteria":186,"healthyVolunteers":16,"sex":187,"minAge":18,"maxAge":188,"enrollmentInfo":189,"targetDuration":4,"studyType":22,"phases":191,"briefSummary":192,"conditions":193,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":4},"100541842","implementation-of-prep-care-among-women-in-family-planning-clinics-100541842","NCT06335121","Implementation of PrEP Care Among Women in Family Planning Clinics","Inclusion Criteria:\n\n* Eligible participants include ciswomen presenting at a PPIL health center with a positive STI test (syphilis, gonorrhea, or chlamydia) and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling.\n\nExclusion Criteria:\n\n\\- Participants will be excluded if they are not PrEP eligible, have a negative STI test, or are not identified in the EHR.","FEMALE","45 Years",{"count":190,"type":21},250,[24],"This study will evaluate implementation strategies to address barriers and increase uptake of PrEP among Black cisgender women in Planned Parenthood of Illinois (PPIL) health centers.",[29,60,194],"Prevention","2026-01-21",{"date":197,"type":34},"2026-01-22",{"date":199,"type":21},"2026-12",{"date":201,"type":21},"2027-06",{"name":203,"class":41},"Rush University Medical Center",{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":208,"acronym":209,"eligibilityCriteria":210,"healthyVolunteers":16,"sex":187,"minAge":211,"maxAge":212,"enrollmentInfo":213,"targetDuration":4,"studyType":22,"phases":215,"briefSummary":216,"conditions":217,"keywords":222,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":232,"completionDateStruct":234,"leadSponsor":236,"locationsCount":131},"100573201","the-integrated-female-sexually-transmitted-infection-testing-for-hiv-epidemic-control-through-prep-in-step-study-100573201","NCT06743204","The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study","IN-STEP","Inclusion criteria:\n\n* Sexually active females aged 15-39 years,\n* resident in Rakai Community Cohort Study (RCCS) communities and who have participated in the most recent RCCS survey will be eligible to participate irrespective of their HIV serostatus.\n* Pregnant women will be included in this study\n* Additionally, eligibility criteria include participation in the most recent RCCS with consent to store and test plasma specimens collected during the RCCS visit,\n* consent to be re-contacted for future studies, and\n* willingness to be randomized in IN-STEP.\n\nExclusion criteria:\n\n* Individuals incapable of providing consent or\n* not meeting the above criteria will be excluded from the study.","15 Years","39 Years",{"count":214,"type":21},5560,[24],"Globally, new HIV infections are concentrated in eastern and southern Africa where the infections are largely acquired by women outside of known key populations. Identifying African women at high risk for HIV acquisition and successfully engaging them in HIV prevention services, particularly pre-exposure prophylaxis (PrEP) programs, is an urgent global health priority. The U.S. President's Emergency Plan for AIDS Relief program in Africa typically relies on self-reported risk screening tools (SRST) to target HIV testing and refer individuals for PrEP. However, these tools have low to moderate sensitivity, missing many women at high risk for HIV. This is partly due to underreporting of risk factors, but also because many African women are at heightened HIV risk solely through relationships with high-risk male partners. Moreover, many African women enrolled into PrEP programs stop using PrEP within months of initiation. Decades of research shows that curable sexually transmitted infections (cSTI) are objective markers of future HIV risk, but cSTI testing largely has been omitted from African HIV programs. With the advent of lower cost multiplex cSTI testing and point of care diagnostics, there is new opportunity to determine whether integrating female cSTI testing services into HIV programs can improve HIV epidemic control. Here, the investigators will conduct an individually randomized effectiveness implementation trial of SRST plus cSTI diagnostic testing for chlamydia, gonorrhea, trichomonas, and syphilis compared to SRST alone to increase PrEP use among cis-gender African women aged 15-39 years. The investigators hypothesize that cSTI testing will increase PrEP use primarily through (i) improved identification of women at high risk for HIV and (ii) enhancement of self-perceived HIV risk. The proposed research will be nested within the Rakai Community Cohort Study, a population-based HIV surveillance cohort in Uganda. In Aim 1, \\~4,500 HIV-negative women will be individually randomized 1:1 to PrEP screening based on SRST plus cSTI diagnostic testing (intervention) versus PrEP screening based on SRST alone (control arm). Both arms will be offered syndromic case management for cSTIs and syphilis testing for pregnant women (standard of care). The primary outcomes will be PrEP uptake, adherence, and persistence, assessed through clinical records and drug level testing. In Aim 2, the investigators will perform a mixed-methods, implementation science evaluation of female cSTI testing for HIV prevention and control. The investigators will use qualitative and quantitative methods to assess the mechanisms, barriers, and facilitators to improving PrEP outcomes through cSTI testing and how this varies by cSTI pathogen, SRST outcomes, and demographic profiles. In Aim 3, the investigators will use mathematical models to evaluate different cSTI testing approaches to reduce HIV incidence at a population level by considering what cSTIs to screen for, in what health care settings, and at what cost thresholds. The investigators will also model broader health benefits of cSTI testing. Results from this study will provide actionable, population-level information to inform strategic delivery of high impact HIV prevention through integrated HIV and cSTI programming in Africa.",[218,219,220,221,60,29],"Gonorrhea Female","Chlamydia Females","Syphilis Female","Trichomonas Vaginalis",[223,224,60,225,226,227,58,228],"Sexually Transmitted Infections (STI)","Diagnostics","Women","Africa","Uganda","Adolescent Girls and Young Women (AGYW)","2025-09-09",{"date":231,"type":34},"2025-09-15",{"date":233,"type":34},"2025-09-08",{"date":235,"type":21},"2029-01-31",{"name":237,"class":41},"Johns Hopkins University",{"id":239,"slug":240,"hasResults":11,"nctId":241,"briefTitle":242,"officialTitle":243,"acronym":244,"eligibilityCriteria":245,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":246,"enrollmentInfo":247,"targetDuration":4,"studyType":22,"phases":249,"briefSummary":250,"conditions":251,"keywords":253,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":257,"lastUpdatePostDateStruct":258,"startDateStruct":260,"completionDateStruct":262,"leadSponsor":264,"locationsCount":131},"100576444","p3-trial-estimating-the-impact-of-a-multilevel-multicomponent-intervention-to-increase-uptake-of-hiv-testing-and-biomedical-hiv-prevention-among-african-americanblack-gay-bisexual-and-same-gender-loving-men-100576444","NCT06785376","P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American\u002FBlack Gay, Bisexual, and Same-gender Loving Men","Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American\u002FBlack Gay, Bisexual and Same-gender Loving Men","P3","Inclusion Criteria:\n\n1. assigned biological male sex at birth;\n2. 18-65 years of age;\n3. self-identify as: Black, African-American, Afro-Caribbean, Black African, Afro-Latino or multiethnic Black;\n4. reside in the NYC metro area; (5) not HIV-positive (tested before randomization);\n\n6\\) report insertive or receptive anal intercourse with another man in the past six months; 7) not currently on PEP or PrEP; 8) communicate in English or Spanish; 9) provide informed consent for the study.\n\nExclusion Criteria:\n\n* Sexual identity is not an exclusion criterion\n* potential participants who self-identify as Latino must also identify as Black (as per above) to be included","65 Years",{"count":248,"type":21},480,[24],"The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP\u002FPrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP\u002FPrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social\u002Fmedia campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.",[252,29],"HIV Testing",[254,59,255,256],"HIV testing","HIV prevention","men who have sex with men","2025-01-16",{"date":259,"type":34},"2025-01-21",{"date":261,"type":34},"2024-12-19",{"date":263,"type":21},"2028-02-28",{"name":265,"class":41},"Columbia University"]